1. Introduction {#s0005}
===============

Pelvic exenteration (PE) has impact on quality of life, body image and sexual functioning ([@b0060]). In two studies of quality of life after PE, approximately 30% of patients who retained vaginal function resumed sexual activity post-operatively ([@b0060], [@b0015]). [@b0060] found women who underwent vaginal reconstruction had improved self-confidence. Anatomically, vaginal reconstruction assists in wound closure, fills large pelvic defects and can improve blood supply from the vascular flap ([@b0055]). For many patients, vaginal reconstruction is an important addition to PE ([@b0060], [@b0015]).

Vaginal defects were classified by [@b0050] as type 1 for partial longitudinal defects resulting from anterior or posterior exenteration, and type 2 for circumferential defects resulting from total PE. Multiple types of neovagina have been described including bowel segment flaps, myofascial flaps, myocutaneous flaps, and myoperitoneal flaps ([@b0055], [@b0025], [@b0010]). The ideal neovagina should have adequate dimensions, normal appearance and function with minimal donor defect ([@b0075]). Techniques used for vaginal reconstruction include the rectus abdominis myocutaneous (RAM) flap and the gracilis myocutaneous flap. Myocutaneous grafts can be problematic due to hair, bulk in obese patients, donor site defects, and not generating mucosa ([@b0045], [@b0065]), whereas RAMP flaps spare the abdominal skin and anterior rectus sheath, do not require additional incisions, have less bulk in obese patients than myocutaneous grafts, and the peritoneum has undergone metaplasia to mucosa in histologic studies ([@b0035]). [@b0035] originally described the transversus and rectus abdominis musculoperitoneal (TRAMP) composite flap which includes the rectus abdominis muscle in continuity with the epigastric part of the transversus abdominis muscle, posterior rectus and transversalis fascia and parietal peritoneum. RAMP flaps have subsequently been described that include only the rectus abdominus muscle, the posterior rectus sheath and the peritoneum ([@b0075]).

Despite the benefits of RAMP flaps, there is limited literature about this technique. The aim of this study is to describe the indications, technique, and results of vaginal reconstruction using RAMP flaps from the literature and experiences at Sunnybrook Health Sciences Center.

2. Methods {#s0010}
==========

A literature review identified published cases of RAMP flaps for vaginal reconstruction and a manual review of the cases' references identified additional articles. The literature search was conducted in Ovid MEDLINE 1946 to November week 2 2018. The search strategy was designed with our academic hospital library information specialist. Search terms combined "vagin\*.mp.kw" OR "neovagin\*.mp.kw" with Reconstructive Surgical Procedures OR Surgical Flaps OR Rectus Abdominis/su\[Surgery\] OR Myocutaneous flap OR (rectus abdom\* adj3 flap?)mp,kw OR (rectus muscle? adj3 flap?).mp,kw OR (myoperiton\* adj3 flap?).mp,kw OR (musculoperiton\* adj3 flap?).mp,kw OR musculo-periton\* adj3 flap?).mp,kw OR RAMP.mp.kw. We excluded animal studies. The resulting titles and abstracts were reviewed by two of the study authors to identify studies for inclusion. All cases of vaginal reconstruction using a RAMP flap from 2007 to 2019 at Sunnybrook Health Sciences Center were reviewed. Research Ethics Board approval was obtained. Cases were identified using ICD codes for vaginal reconstruction. The identified charts were reviewed to find cases where RAMP flaps were used. Collected data included patient age, BMI, comorbidities, diagnosis, indication for vaginal reconstruction, concurrent surgical procedures, intraoperative and post-operative complications, presence of post-operative vaginal shortening, stenosis, fistula, donor site complications and oncologic outcome where applicable.

2.1. Surgical technique {#s0015}
-----------------------

The donor site for the RAMP flap was chosen based on existing scars and stoma sites. The flap was harvested by dissecting the rectus abdominus muscle from the anterior rectus sheath. The peritoneum underlying the rectus muscle was sutured to the muscle to prevent shearing. The muscle was transected at the level of the umbilicus and mobilized medially and posteriorly ([Fig. 1](#f0005){ref-type="fig"}A). The inferior epigastric vessels were preserved ([Fig. 1](#f0005){ref-type="fig"}B). The muscle with its peritoneum was rotated inwards to create an augmentation of the vagina, with the peritoneum sutured to the vaginal mucosa in a configuration dependent on the type of vaginal defect ([Fig. 1](#f0005){ref-type="fig"}C). An in-house custom-made mould was placed vaginally and sutured to the vulva. The mould was created using Keetron PEEK Classix Life Sciences Grade material and machined manually at the Odette Cancer Centre at SHSC on a lathe and milling machine (see [Supplemental Content 1](#s0055){ref-type="sec"}). The vaginal mould was removed on post-operative day 5. The patients were given vaginal dilators to use with lubricant 3 times daily upon discharge until the onset of sexual activity. [Fig. 2](#f0010){ref-type="fig"} depicts the vagina at 4-weeks post-operative.Fig. 1(A) The rectus abdominus muscle transected at the level of the umbilicus and mobilized medially and posteriorly. (B) The rectus abdominus muscle with the preserved inferior epigastric vessels. (C) An intraperitoneal view of the rectus abdominus muscle flap.Fig. 2The vagina at 4-weeks post-operation.

3. Results {#s0020}
==========

Our search generated 1724 publications and we identified 21 cases of RAMP flap vaginal reconstruction from 5 publications ([@b0055], [@b0075], [@b0045], [@b0035], [@b0070]). Most of the studies used TRAMP flaps. There was a single series of 5 patients that used RAMP flaps alone ([Table 1](#t0005){ref-type="table"}). The identified studies did not specify the patient's BMI or abdominal wall thickness and most did not describe the reason for choosing RAMP flap over a myocutaneous flap. Of the 21 cases identified, 11 had partial longitudinal (type 1) vaginal defects, 5 had circumferential (type 2) defects and 5 had unspecified defects. Eight patients with circumferential (N = 3) or unspecified (N = 5) defects developed vaginal stenosis. None of the patients with type 1 defects developed vaginal stenosis. The studies by [@b0055], [@b0070] compared myoperitoneal flaps to corresponding myocutaneous flaps ([@b0075], [@b0045]). Both studies found that myoperitoneal flaps had higher rates of vaginal stenosis than myocutaneous flaps. [@b0055] compared 5 TRAMP flaps to 5 transverse rectus abdominis myocutaneous (TRAM) flaps. They found TRAMP flaps had complete or partial vaginal stenosis whereas TRAM flaps maintained at least 6 cm vaginal length by 6 months after surgery, but the type of vaginal defects were not specified ([@b0055]). [@b0070] compared 32 vertical rectus abdominus myocutaneous (VRAM) and TRAM flaps to 7 TRAMP flaps. The vaginal defect was type 1 in 25% of RAM flaps and 57% of RAMP flaps. They noted flap loss in 6% vs 0%, stricture or stenosis in 13% vs. 43%, rectovaginal fistula in 6% vs. 0%, superficial donor site wound separation in 13% vs 43%, fascial dehiscence in 3% vs. 0%, and hernia in 0% vs. 29% in the RAM and RAMP groups, respectively ([@b0070]). All cases of vaginal stenosis or shortening among RAMP flaps were in patients who had type 2 vaginal defects.Table 1Literature review cases of RAMP flap vaginal reconstruction.AuthorYearDiagnosisPrimary procedureFlap type\# of casesVaginal defect typeDonor site complicationsFlap complicationsSexually activeHockel1996Recurrent Cx CAAnterior exenterationTRAMP2Type 1 (2)NoneNone2/2Anal cancerPosterior exenteration  Niazi et al.2001Vag stenosis after RT for Cx CAHyst, upper vaginectomyTRAMP2Type 2 (2)NoneNone1/2RKH syndromeNeovagina  Rietjens2002Advanced Cx CA after NACTAnterior exenterationTRAMP5NDNoneStenosis (5)0/5Recurent vulvar CAHyst-BSO-perineal resectionRecurrent Cx CAAnterior exenterationRecurrent Cx CAAnterior exenterationRecurrent Endo CAAnterior exenteration  Soper et al.2005Cervical CA (2)Total exenteration (1)TRAMP7Type 1 (4)Hernia (2)Stenosis (3)NDVaginal CA (3)Anterior exenteration (4)Type 2 (3)SW infection (3)\[all in type 2 defects\]Other (2)Radical vaginectomy (2)  Wu et al.2005Rectal cancerAPR, post vaginectomyRAMP5Type 1 (5)SW infection (1)None4/5Rectal cancerAPR, post vaginectomyNeobladder-vaginal fistula after bladder CADebridement of fistula, closure of neobladderPelvic sarcomaAPR, post vaginectomyRV fistula from Crohn\'s diseaseTPC, debridement of fistula[^1]

3.1. Case series {#s0025}
----------------

We identified nineteen cases of vaginal reconstruction at our institution during the study period, and five cases used RAMP flaps. Pre-operative diagnosis, intra-op findings, and post-operative outcomes are summarized in [Table 2](#t0010){ref-type="table"}. Case 1 died 18 days post-operatively due to complications. Case 2 had a RAMP flap reconstruction for a circumferential vaginal defect. Her vaginal stent was removed on POD 5 and her vagina was 5--7 cm and 3--4 cm narrow. She died 13 months post-operatively due to disease recurrence. Case 3 had a RAMP flap reconstruction of a circumferential vaginal defect. She initially used a vaginal dilator twice per day, had a normal vaginal length 6 weeks post-operatively, and despite vaginal shortening to 3--4 cm was having intercourse at 3-months post-operative. Case 4 had a RAMP flap reconstruction for a partial longitudinal vaginal defect. The vaginal mould was removed on POD 5 and she was discharged with vaginal dilators. At 4-weeks post-operative, she had a normal vaginal length and re-epithelialized with vaginal mucosa. Case 5 had a RAMP flap reconstruction for a circumferential vaginal defect. The vaginal mould was removed on POD 7 and she was discharged with vaginal dilators. By 4 months postoperative, the vagina was normal in length and re-epithelialized with vaginal mucosaTable 2Case series of vaginal reconstruction using RAMP flaps at SHSC.Case 1Case 2Case 3Case 4Case 5Age7146505341BMI\>404039\<30\<30DiagnosisRecurrent vaginal CA. SCC anterior vaginal vaultRecurrent cervical CA. SCC posterior cervix and upper vaginaVaginal stenosis (1--2 cm) after RT for anal CAVaginal melanomaRecurrent (2nd) cervical adenocarcinoma  Primary SurgeryAnterior exent, ileal conduit, FS adenopathy and margins negativeTotal exent, LAR, ileal conduit, FS adenopathy negativeTAH-BSO-vaginectomyTAH-BSO, Radical ant. vaginectomy, urethrectomy, partial bladder resection, Mitrofanoff procedureTotal exenteration, peri-aortic lymphadenectomy, ileal conduit, FS adenopathy and peri-ureteric tissue negativeRadiation14 years prior to recurrence6 months prior to recurrence15 months prior to vaginal stenosisNo2 years (EPR and VB) and 4 months (IB) prior to 2nd recurrenceType of vaginal defectType 2Type 2Type 2Type 1Type 2  Complications from 1° surgeryDeath from SMV thrombosis POD 18Leak from LAR, urosepsisSuperficial wound infectionNoneSBO resolved, small fascial dehiscence  Follow Up Time18 days13 months3 months20 months4 monthsFlap complicationsNDRectovaginal fistulaVaginal shortening (length 3--4 cm)NoneNone  Donor site complicationsNDNoneSuperficial wound infectionNoneNoneFlap outcomeNDVagina 5--7 cm long, 3--4 cm wideVagina 3--4 cm longNormal length, re-epithelializedVagina normal length, re-epithelialized[^2]

4. Discussion {#s0030}
=============

PE has the potential to cure patients with central pelvic disease, but is associated with high perioperative morbidity and poor global health and body image scores ([@b0015]). Vaginal reconstruction helps fill the pelvic dead space, improves local blood supply and can restore sexual function ([@b0005], [@b0030]). For reconstruction of circumferential vaginal defects, the RAM flaps are most popular due to their robust blood supply from the inferior epigastric vessels, large arc of rotation, low rate of necrosis, and high patency rates without using vaginal dilators ([@b0020]). However, RAM flaps use hair-bearing skin that does not undergo metaplasia to vaginal mucosa, and requires a moderate to large amount of abdominal wall skin and anterior rectus sheath. Obesity is a relative contraindication to a RAM flap as it will be too bulky to fit in the pelvic space which could compromise the flap's blood supply ([@b0065]). In contrast, the RAMP flap spares the abdominal skin, fat, and anterior rectus sheath, has less bulk in obese patients and the peritoneum undergoes metaplasia to vaginal mucosa ([@b0035]).

In three out of our five cases, a RAMP was used for a circumferential vaginal defect due to patient obesity. One patient died of complications from her exenteration procedure, one developed a rectovaginal fistula due to a leak from her LAR and the third had vaginal shortening by three months after surgery. The fourth circumferential vaginal defect reconstruction with a normal BMI had a recurrence at 4 months. The two patients with no flap complications were Case 4, with a normal BMI and a type 1 vaginal defect, and case 5, with a normal BMI and a type 2 vaginal defect. These are consistent with the literature, but potentially impacted by Case 4 not having prior radiation. Our literature review demonstrated that none of the patients with documented type 1 vaginal defects developed vaginal stenosis or shortening and 7/21 cases resumed sexual activity after RAMP flap reconstruction. For type 2 vaginal defects, RAMP flaps have higher rates of vaginal stenosis and shortening than RAM flaps, and seem much more dependent on the post-operative use of vaginal dilators.

Due to limited numbers of cases in literature directly comparing RAM to RAMP flaps, we were unable to determine whether there is a difference in donor site complications. Interestingly, 4/5 of the publications used TRAMP composite flaps ([@b0055], [@b0045], [@b0035], [@b0070]). There was only a single series before this one that used exclusively RAMP flaps ([@b0075]). Combining the 21 cases of RAMP flaps from the literature and our series of 5, there were 2 (8%) with donor site hernias. Both donor site hernias were in patients with TRAMP flap reconstruction in the series by [@b0070]. [@b0070] compared 32 TRAM and RAM to 7 TRAMP flaps. They found fascial dehiscence in 3% vs. 0%, and hernia in 0 vs. 29% of TRAM/RAM vs. TRAMP flaps, respectively. The authors concluded that RAMP flaps have higher donor site complication rates than RAM flaps. However, all of their myoperitoneal flaps included a portion of the tranversus abdominis muscle and the average BMI was higher in the group undergoing myoperitoneal flap reconstruction, both which would lead to a higher risk of donor site complications. Furthermore, [@b0070] described one patient who required placement of synthetic mesh to repair a 20 × 20 cm ventral hernia at the time of anterior exenteration with RAMP flap neovaginal reconstruction, which accounts for one (14%) of the reported hernias in the RAMP group. We did not find any studies directly comparing pure RAMP flaps to VRAM flaps, however it seems intuitive that without removing skin or anterior fascia, donor site complications should be reduced with RAMP flaps compared to RAM flaps.

5. Conclusion {#s0035}
=============

In summary, the RAMP flap may be useful for the reconstruction of partial longitudinal vaginal defects, particularly in obese patients. RAMP flap loss and major donor site complications are low, and the use of post-operative vaginal stents and dilators are important to maintain vaginal patency. For circumferential vaginal defects, the RAMP flap has a high rate of vaginal stenosis and shortening, and other options such as RAM flaps should be considered.
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The following are the Supplementary data to this article:Supplementary Fig. 1The in-house custom-made vaginal mould.

Supplementary data to this article can be found online at <https://doi.org/10.1016/j.gore.2020.100567>.

[^1]: Cx, cervical; CA, cancer; TRAMP, transversus and rectus abdominis musculoperitoneal; Vag, vaginal; RT, radiation therapy; Hyst, hysterectomy; RKH, Rokitansky-Kustner-Hauster; NACT, neoadjuvant chemotherapy; Endo, endometrial; BSO, bilateral salpingo-oophorectomy; APR, abdominoperineal resection; post, posterior; RV, rectovaginal; TPC total proctocolectomy; SW, superficial wound; RAMP, rectus abdominis myoperitoneal.

[^2]: CA, cancer; SCC, squamous cell carcinoma;RT, radiation therapy; exent, exenteration; FS, frozen section; LAR, low-anterior resection; TAH, total abdominal hysterectomy; BSO, bilateral salpingo-oophorectomy; ant, anterior; EPR, external pelvic radiation; VB, vault brachytherapy; IB, interstitial brachytherapy; 1°, primary; SMA, superior mesenteric artery; POD, post-operative day; SBO, small bowel obstruction; ND, natural death.
